Glycometabolism Disorder And Acute Coronary Syndrome

Objectives and Methods The aim of this review was to evaluate the clinical characteristics of acute coronary syndrome (ACS) patients with hyperglycemia and to explore impact of blood glucose level on recent prognosis of ACS. In the backgroud of frequent glycometabolism disorder diseases, the recent prognosis between diabetes mellitus(DM),stress hyperglycemia (SHG), metabolic syndrome(MS) and ACS was analyzed.The current definition of MS focuses on the individual accumulation of multiple cardiovascular risk factors. Excepting hyperglycemia,there are fatness, hypertension and hyperlipemia.Results and Conclusions Onsting silent, painless myocardial infarction in patients with DM were significantly more than those in the patients without DM and the age of DM group was younger than that without DM.With rising of blood glucose level in patients with DM or SHG, the incidence rate of ill prognosis,in-hospital death,serious cardiac arrhythmias, backward heart failure,cardiac shock were increased.The level of blood glucose could be used as the parameters of judgeing the patient's prognosis. So hyperglycemia of patients with ACS should be strictly controlled by multiple subcutaneous insulin injection generally. Continuous subcutaneous insulin infusion(CSII) be used in the patients with hyperglycaemia significantly,diabetic ketoacidosis(DKA) or hyperosmolar nonketotic diabetic coma. Glucose level should be monitored intimately in order to prevent hypoglycemia in the process.